Cancer Patients Thankful to Nobel Winner Honjo

Society Lifestyle Science Technology

Tokyo, Oct. 3 (Jiji Press)--After Monday's announcement that this year's Nobel Prize in Physiology or Medicine goes to Tasuku Honjo, professor at Kyoto University, cancer patients voiced gratitude for his contributions to the development of the Opdivo cancer drug.

Koichi Shimizu, a 41-year-old resident of Sakura, Chiba Prefecture, east of Tokyo, was diagnosed with lung cancer in October 2012 following a medical checkup. The cancer was found to have spread to his adrenal glands and brain the next year.

In December 2016, metastasis to the brain occurred again and his cancer was also found to have spread to his spiral cord. He then started treatment with Opdivo.

One month later, Shimizu's tumor marker levels began to decline and his headaches eased. He used Opdivo until around July last year and says he is still in good condition.

"I was shocked" to learn of the first metastasis, Shimizu said, adding that he wondered how long he would live to see the growth of his infant son.

[Copyright The Jiji Press, Ltd.]

Jiji Press